通讯作者: 张涛, hello＿zhangtao@aliyun.com

DOI：10.12201/bmr.202509.00053

Exploring Professor Xiong Yan

• 摘要：非酒精性脂肪性肝病（Non-alcoholic fatty liver disease，NAFLD）病机复杂，中医认为其发生与饮食、情志及体质因素密切相关。基于“消法”理论，系统总结熊焰教授治疗NAFLD的临证经验，重点体现其在病机阐释与分层治疗方面的创新。熊教授提出三大病机关键：饮食不节致脾胃损伤、情志失调致肝郁乘脾、禀赋不足致痰瘀互结，三者相互影响，终致肝脾失调、痰瘀阻滞。在治疗上，以“消法”为核心，分层施治：消食导滞、醒脾化浊以健运中焦；疏肝解郁、消滞和络以调畅气机；消痰化瘀、扶正通络以祛邪固本，并创立经验方“脂康饮”以兼顾肝脾、痰瘀同治，体现其临证思路的独特性和实用性，为NAFLD的中医治疗提供了新的有效方药与临床路径。

  关键词： 非酒精性脂肪性肝病，消法，脂康饮，经验

   

  Abstract: Non-alcoholic fatty liver disease (NAFLD) has a complex pathogenesis. In traditional Chinese medicine (TCM), its occurrence is closely associated with dietary habits, emotional factors, and constitutional predisposition. Based on the “Xiao Fa” (dispersion method) theory, this article systematically summarizes Professor Xiong Yan’s clinical experience in treating NAFLD, highlighting innovations in pathological mechanism interpretation and stratified treatment.Professor Xiong identifies three key pathological mechanisms: dietary irregularities leading to spleen-stomach impairment, emotional disorders causing liver stagnation overacting on the spleen, and congenital deficiency resulting in phlegm and stasis binding together. These factors interact, ultimately leading to liver-spleen dysfunction and phlegm-stasis obstruction.Therapeutically, centering on “Xiao Fa,” a stratified treatment approach is adopted: promoting digestion and removing stagnation, awakening the spleen and resolving turbidity to strengthen the middle energizer; soothing the liver and relieving depression, eliminating stagnation and harmonizing collaterals to regulate qi movement; resolving phlegm and dissipating stasis, supporting healthy qi and unblocking collaterals to eliminate pathogens and consolidate constitution. Professor Xiong also developed the empirical formula “Zhi Kang Yin” to simultaneously address the liver and spleen, and treat both phlegm and stasis, reflecting the uniqueness and practicality of his clinical approach. This provides a new effective formula and clinical pathway for TCM treatment of NAFLD.

  Key words: Non-alcoholic fatty liver disease，Therapy of Dispelling，Zhi Kang Yin，Experience

  提交时间：2025-09-24

  版权声明：作者本人独立拥有该论文的版权，预印本系统仅拥有论文的永久保存权利。任何人未经允许不得重复使用。
• html

• 图表

• 王馨雨, 张淑娟. GLP-2在非酒精性脂肪性肝病中的研究进展. 2025. doi: 10.12201/bmr.202502.00018

  李治辉, 陈芝芸. 常见环境污染物对非酒精性脂肪性肝病的影响. 2025. doi: 10.12201/bmr.202506.00049

  彭玉冰, 牛晓珊. NF-κB在非酒精性脂肪肝病中的药物研究进展. 2024. doi: 10.12201/bmr.202410.00006

  刘萌萌, 李雪, 费悦, 徐霞红. 基于NHANES数据库探索血清铁蛋白与青少年代谢相关脂肪性肝病的相关性. 2025. doi: 10.12201/bmr.202503.00012

  贾晨, 巩 艳, 韩懿晶, 姜佳楠, 刘唯正, 张大旭, 吕文平. 心理压力与代谢相关脂肪性肝病的相关性研究. 2022. doi: 10.12201/bmr.202204.00003

  易小莲. 儿童代谢相关脂肪性肝病的治疗与研究进展. 2025. doi: 10.12201/bmr.202507.00044

  黄思琪, 肖志鸿. 论“肝病实脾”与“肠-肝轴”理论在代谢相关脂肪性肝病防治中的互通与应用. 2025. doi: 10.12201/bmr.202509.00057

  武文青, 宋思梦, 王释亮, 伍大华, 谢乐. 周慎教授基于“阴损及阳”理论从肝肾论治迟发性运动障碍经验. 2025. doi: 10.12201/bmr.202509.00038

  刘永淳, 罗良涛, 高忠英. 高忠英教授从“胃痈”理论治疗慢性萎缩性胃炎的经验. 2024. doi: 10.12201/bmr.202410.00062

  丁冠方, 田琳. 田琳教授分型辨治肺腺癌经验. 2025. doi: 10.12201/bmr.202506.00019

• 序号	提交日期	编号	操作
  1	2025-09-12	10.12201/bmr.202509.00053V1	下载

• 公开评论  匿名评论  仅发给作者 提交评论